...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Newco Ownership
Whatever it's valued at really doesn't matter does it? You can't trade it anyways...the same way you couldn't trade RVX Therapeutics even though you owned it with your RVX shares.
Share
New Message
Please login to post a reply